208 related articles for article (PubMed ID: 16310587)
41. Massive variation in Ritalin prescribing.
Gainsbury S
Health Serv J; 2008 Jul; ():5. PubMed ID: 18705035
[No Abstract] [Full Text] [Related]
42. Hematologic and blood biochemistry monitoring during methylphenidate treatment in children with attention-deficit/hyperactivity disorder: 2-year, open-label study results.
Wigal SB; Wilens TE; Wolraich M; Lerner M
Pediatrics; 2007 Jul; 120(1):e120-8. PubMed ID: 17548486
[TBL] [Abstract][Full Text] [Related]
43. Effectiveness and safety of methylphenidate in adult attention deficit hyperactivity disorder in patients with epilepsy: an open treatment trial.
van der Feltz-Cornelis CM; Aldenkamp AP
Epilepsy Behav; 2006 May; 8(3):659-62. PubMed ID: 16504592
[TBL] [Abstract][Full Text] [Related]
44. An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder.
Chavez B; Sopko MA; Ehret MJ; Paulino RE; Goldberg KR; Angstadt K; Bogart GT
Ann Pharmacother; 2009 Jun; 43(6):1084-95. PubMed ID: 19470858
[TBL] [Abstract][Full Text] [Related]
45. [Hyperkinetic syndrome and dyslexia. Medical help for the hyperactive child].
Stiefelhagen P
MMW Fortschr Med; 2002 May; 144(21):4-8. PubMed ID: 12134423
[No Abstract] [Full Text] [Related]
46. Association of the adrenergic alpha2A receptor gene with methylphenidate improvement of inattentive symptoms in children and adolescents with attention-deficit/hyperactivity disorder.
Polanczyk G; Zeni C; Genro JP; Guimarães AP; Roman T; Hutz MH; Rohde LA
Arch Gen Psychiatry; 2007 Feb; 64(2):218-24. PubMed ID: 17283289
[TBL] [Abstract][Full Text] [Related]
47. Photic responses in "minimal brain dysfunction".
Milstein V; Small JG
Dis Nerv Syst; 1974 Aug; 35(8):355-7. PubMed ID: 17894071
[No Abstract] [Full Text] [Related]
48. Human subjects research. Pediatric study of ADHD drug draws high-level public review.
Couzin J
Science; 2004 Aug; 305(5687):1088-9. PubMed ID: 15326317
[No Abstract] [Full Text] [Related]
49. Single-dose pharmacokinetics of multilayer-release methylphenidate and immediate-release methylphenidate in children with attention-deficit/hyperactivity disorder.
Quinn D; Bode T; Reiz JL; Donnelly GA; Darke AC
J Clin Pharmacol; 2007 Jun; 47(6):760-6. PubMed ID: 17395894
[TBL] [Abstract][Full Text] [Related]
50. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
Quintana H; Cherlin EA; Duesenberg DA; Bangs ME; Ramsey JL; Feldman PD; Allen AJ; Kelsey DK
Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731
[TBL] [Abstract][Full Text] [Related]
51. Zinc deficiency in attention-deficit hyperactivity disorder.
Toren P; Eldar S; Sela BA; Wolmer L; Weitz R; Inbar D; Koren S; Reiss A; Weizman R; Laor N
Biol Psychiatry; 1996 Dec; 40(12):1308-10. PubMed ID: 8959299
[No Abstract] [Full Text] [Related]
52. Race for perfection: children's rights and enhancement drugs.
Powers T
J Law Health; 1998-1999; 13(1):141-69. PubMed ID: 10788220
[No Abstract] [Full Text] [Related]
53. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P
Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137
[TBL] [Abstract][Full Text] [Related]
54. Improving decision making in the treatment of ADHD.
Vitiello B
Am J Psychiatry; 2008 Jun; 165(6):666-7. PubMed ID: 18519529
[No Abstract] [Full Text] [Related]
55. Methylphenidate-associated enuresis in attention deficit hyperactivity disorder.
Ghanizadeh A
J Pediatr Urol; 2008 Aug; 4(4):306-7. PubMed ID: 18644535
[TBL] [Abstract][Full Text] [Related]
56. Attention-deficit hyperactivity disorder and anesthesia.
Forsyth I; Bergesio R; Chambers NA
Paediatr Anaesth; 2006 Apr; 16(4):371-3. PubMed ID: 16618289
[No Abstract] [Full Text] [Related]
57. [Without treatment the crash threatens].
Einecke U
MMW Fortschr Med; 2009 Jan; 151(5):14-6. PubMed ID: 19391404
[No Abstract] [Full Text] [Related]
58. Efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder.
Lee SI; Hong SD; Kim SY; Kim EJ; Kim JH; Kim JH; Park MK; Park S; Park JH; Oh EY; Lim TS; Cheong S; Cho IH; Choi JW
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):210-6. PubMed ID: 17046131
[TBL] [Abstract][Full Text] [Related]
59. Attention deficit hyperactivity disorder across the lifespan: the child, adolescent, and adult.
Greydanus DE; Pratt HD; Patel DR
Dis Mon; 2007 Feb; 53(2):70-131. PubMed ID: 17386306
[TBL] [Abstract][Full Text] [Related]
60. [Malnutrition in children with DAMP?].
Andersen LL
Ugeskr Laeger; 2009 Mar; 171(10):824. PubMed ID: 19280776
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
